selected publications
- Shedding Light on PARP Inhibitor Response through Functional Imaging. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023 Editorial Article GET IT
- Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management. Gynecologic oncology. 2023 Academic Article GET IT
-
Ovarian cancer mutational processes drive site-specific immune evasion.
Nature.
2022
Academic Article
GET IT
Times cited: 13 -
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort.
Cancer discovery.
2022
Academic Article
GET IT
Times cited: 4 - Activating STAT5B mutations can cause both primary hypereosinophilia and lymphocyte-variant hypereosinophilia. Leukemia & lymphoma. 2022 Letter GET IT
-
MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2022
Academic Article
GET IT
Times cited: 12 -
Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2022
Academic Article
GET IT
Times cited: 3 - Germline SMARCA4 Deletion as a Driver of Uterine Cancer: An Atypical Presentation. 2022 GET IT
-
Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
European urology.
2022
Academic Article
GET IT
Times cited: 3 -
Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.
Cancer.
2022
Academic Article
GET IT
Times cited: 4 -
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2022
Academic Article
GET IT
Times cited: 1 -
Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis.
Gynecologic oncology.
2022
Academic Article
GET IT
Times cited: 5 -
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
2022
Academic Article
GET IT
Times cited: 3 -
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer.
Nature cancer.
2022
Academic Article
GET IT
Times cited: 18 -
BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation.
Blood.
2022
Academic Article
GET IT
Times cited: 5 -
Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome.
Genetics in medicine : official journal of the American College of Medical Genetics.
2022
Academic Article
GET IT
Times cited: 1 -
Reduced Plasmacytoid Dendritic Cell Output Is Associated With High Risk in Low-grade Myelodysplastic Syndrome.
HemaSphere.
2022
Academic Article
GET IT
Times cited: 3 -
Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.
Annals of oncology : official journal of the European Society for Medical Oncology.
2022
Academic Article
GET IT
Times cited: 8 - Abnormal B-lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia. Cytometry. Part B, Clinical cytometry. 2021 Academic Article GET IT
-
Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2021
Academic Article
GET IT
Times cited: 3 -
Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors.
NPJ genomic medicine.
2021
Academic Article
GET IT
Times cited: 150 -
Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
2021
Comment
GET IT
Times cited: 5 -
TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes.
Cancers.
2021
Academic Article
GET IT
Times cited: 93 -
Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer.
2021
GET IT
Times cited: 445 -
Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes.
JCO oncology practice.
2021
Review
GET IT
Times cited: 17 -
Diagnosis and management of an endometrial cancer patient with Cowden syndrome.
2021
GET IT
Times cited: 2 -
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer.
NPJ breast cancer.
2021
Academic Article
GET IT
Times cited: 45 -
The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?.
Journal of the National Comprehensive Cancer Network : JNCCN.
2021
Review
GET IT
Times cited: 3 -
Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy.
Gynecologic oncology.
2021
Academic Article
GET IT
Times cited: 8 -
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS.
Nature communications.
2021
Academic Article
GET IT
Times cited: 42 -
Therapeutic Implications of Germline Testing in Patients With Advanced Cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2021
Academic Article
GET IT
Times cited: 37 -
Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.
Gynecologic oncology.
2021
Review
GET IT
Times cited: 18 -
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
Blood.
2021
Academic Article
GET IT
Times cited: 35 -
Prevalence and Characterization of Biallelic and Monoallelic NTHL1 and MSH3 Variant Carriers From a Pan-Cancer Patient Population.
JCO precision oncology.
2021
Academic Article
GET IT
Times cited: 7 -
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow Cytometry.
The Journal of molecular diagnostics : JMD.
2020
Academic Article
GET IT
Times cited: 12 -
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2020
Academic Article
GET IT
Times cited: 17 -
FGFR1 Rearrangement Guides Diagnosis and Treatment of a Trilineage B, T, and Myeloid Mixed Phenotype Acute Leukemia.
2020
GET IT
Times cited: 2 -
RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.
Urology.
2020
Academic Article
GET IT
Times cited: 4 -
BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer.
JCO precision oncology.
2020
Academic Article
GET IT
Times cited: 18 -
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2020
Academic Article
GET IT
Times cited: 3 -
Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma.
The American journal of surgical pathology.
2020
Academic Article
GET IT
Times cited: 12 -
Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery.
Journal of gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 17 -
Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer.
Gynecologic oncology.
2019
Academic Article
GET IT
Times cited: 10 - The t(11;14)(q13;q32)/CCND1-IGH translocation in chronic lymphocytic leukaemia/small lymphocytic lymphoma: an unusual genetic aberration during the natural clinical course. Histopathology. 2019 Letter GET IT
- Transformation of monoclonal B lymphocytosis to Epstein-Barr virus-positive large B-cell lymphoma with intermediate features between diffuse large B-cell lymphoma and classic Hodgkin lymphoma. AJSP: reviews & reports. 2019 Academic Article GET IT
-
Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers.
Current oncology reports.
2018
Review
GET IT
Times cited: 33 -
Obesity's impact on survival is independent of dose adjustments in neoadjuvant chemotherapy in women with breast cancer.
Breast cancer research and treatment.
2017
Letter
GET IT
Times cited: 2